Le Lézard
Classified in: Health, Science and technology, Covid-19 virus
Subject: Product/Service

University of Adelaide Begins Human Trial of Omicron COVID Vaccine Booster Using PharmaJet Needle-free System


PharmaJet®, a company that has developed and commercialized a needle-free platform to more effectively administer drugs and biologics announced that its partner, University of Adelaide, has started a human trial of a DNA-based COVID-19 vaccine booster using the PharmaJet Tropis® Needle-free Injection System (NFIS).

The DNA-vaccine booster is one of the few vaccines worldwide targeting the Omicron variant, rather than the original strain of the virus. As DNA vaccines can be modified easily the vaccine can be quickly adapted to future variants. Lead investigator, Associate Professor Branka Grubor-Bauk, head of Viral Immunology at the University of Adelaide's Adelaide Medical School commented, "We need to continue developing 'next generation' COVID-19 vaccines because the virus will continue to mutate, particularly in countries with low vaccination rates and high rates of uncontrolled transmission." The vaccine is being exclusively administered using the PharmaJet Tropis® NFIS, which was chosen due to the data from numerous published preclinical and clinical studies demonstrating improved immunogenicity when administering DNA-vaccines.1

Chris Cappello, President and CEO, PharmaJet commented, "We are pleased to be partnering with the University of Adelaide as they begin their Omicron COVID-19 booster vaccine trials. Our partners have published 11 studies comparing delivery methods for DNA vaccines that demonstrate increased immunogenicity when using the PharmaJet Systems."

For more information about PharmaJet visit www.pharmajet.com.

Refer to Instructions for Use to ensure safe injections and to review risks.

1 Data on file

About PharmaJet

PharmaJet's mission is to enable greater access to life improving pharmaceuticals. We are committed to helping our partners realize their research and commercialization goals while making an impact on public health. PharmaJet's Needle-free Injection Systems provide increased vaccine effectiveness, a preferred patient and caregiver experience, and a proven path to market. They are also safe, fast, and easy-to-use. The Stratis® System has U.S. FDA 510(k) marketing clearance, CE Mark, and WHO PQS certification to deliver medications and vaccines either intramuscularly or subcutaneously. The Tropis® System has CE Mark and WHO PQS certification for intradermal injections. For more information visit www.pharmajet.com. Follow us on LinkedIn.


These press releases may also interest you

at 21:40
A news report by Huanqiu.com: At present, a new round of sci-tech revolution and industrial transformation worldwide is greatly influencing production and people's lives. The internet, big data and artificial intelligence are achieving more extensive...

at 21:20
D-Link Corporation unveiled today its much-anticipated DWA-F18 VR Air Bridge, a wireless dongle designed specifically for Meta Quest 2 in an exclusive partnership with Meta. The DWA-F18 VR Air Bridge provides high-performance wireless links between...

at 21:05
Azure Printed Homes (Azure), innovators of 3D printing building technology utilizing recycled plastic, has been chosen by Enfield Housing Corp. for the delivery of seven two-bedroom homes. Enfield Housing Corp.'s mission is to combat gentrification...

at 20:35
"While my staff of 350 people living and working in the predicted landfall of Hurricane Ian began their week with a staff meeting to address client needs and begin discussions about addressing personal needs, a media feeding frenzy broke out, pushing...

at 20:20
This report offers detailed insights and analysis of the major cost drivers, volume drivers, top suppliers, most suitable supplier selection criteria, supplier evaluation metrics, SLA that buyers should consider, and innovations of the Wearable...

at 19:56
The Business Intelligence Group announced that it has awarded StormForge a 2022 Stratus Award for Cloud Computing in their annual business award program. The organization sought to identify the companies, products and people that are offering unique...



News published on 16 august 2022 at 11:10 and distributed by: